Copyright
©The Author(s) 2017.
World J Virol. May 12, 2017; 6(2): 36-45
Published online May 12, 2017. doi: 10.5501/wjv.v6.i2.36
Published online May 12, 2017. doi: 10.5501/wjv.v6.i2.36
TE | APRI | Forns | FIB-4 | YFPI | |
Higher MMP-2 levels | 0.001 | 0.0001 | 0.03 | 0.0009 | 0.004 |
Higher TIMP-2 levels | 0.016 | 0.0001 | 0.024 | 0.0002 | - |
Lower MMP-9 levels | 0.023 | 0.016 | - | 0.03 | 0.043 |
Lower current CD4 counts | - | 0.032 | 0.037 | 0.043 | - |
Older age | - | - | 0.004 | 0.05 | - |
% of the index accounted for by the model | 20.00% | 35.30% | 23.30% | 33.50% | 20.70% |
- Citation: Collazos J, Valle-Garay E, Suárez-Zarracina T, Montes AH, Cartón JA, Asensi V. Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients. World J Virol 2017; 6(2): 36-45
- URL: https://www.wjgnet.com/2220-3249/full/v6/i2/36.htm
- DOI: https://dx.doi.org/10.5501/wjv.v6.i2.36